Naproxen Al (Naproxen)

Naproxen works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are required for the synthesis of prostaglandins. By reducing prostaglandin production, it diminishes inflammation, pain signaling, and fever responses in the body.

The appropriate dose of Naproxen Al is determined by the prescribing clinician based on the patient’s condition, age, weight, and overall health. Patients should follow the exact dosing instructions provided by their healthcare professional and the product label.

Safety of naproxen during pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Naproxen Al.

To order Naproxen Al, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both naproxen and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen generally has a longer half‑life, allowing less frequent dosing, whereas ibuprofen may have a quicker onset but requires more frequent administration. Choice depends on clinical judgment, patient tolerance, and specific therapeutic goals.

Naproxen Al should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product protected from moisture, heat, and direct sunlight. Do not use if the tablet shows signs of damage or discoloration.

Naproxen Al is taken orally, usually with a full glass of water. It may be taken with food or milk to reduce gastrointestinal discomfort, unless otherwise directed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, renal impairment, cardiovascular events such as heart attack or stroke, severe skin reactions (e.g., Stevens‑Johnson syndrome), liver injury, and anaphylactic reactions. Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, blood in stool, sudden swelling, or rash.

Naproxen Al should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulceration or bleeding, severe renal or hepatic impairment, uncontrolled hypertension, and those who have had recent cardiovascular events unless specifically advised by a physician.